• BX Home
  • Drug Marketing: Blog [Page 4]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 433 news and 302 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Blogs

Recent blog posts on this topic.

Paul Gondek Joins CMI's Healthcare Solutions Practice - Advertising an...more

ATLANTA, Ga., Sept. 28, 2012 (SEND2PRESS NEWSWIRE) -- Paul Gondek has joined CMI to expand the company's Healthcare...

The Op-Ed: Pharma Money in an Election Yearmore

(James Love is the director of Knowledge Ecology International, the U.S. co-chair of the Trans-Atlantic Consumer...

The Op-Ed: A Suggestion to Restore Faith in Pharma Studiesmore

(Our first invited guest blogger today is Harlan Krumholz, M.D., of Yale School of Medicine. Dr. Krumholz is the Harold...

Lilly And Social Mediamore

(Editor’s note: Ed’s at a conference in D.C. right now; Deputy Ms. Pharmalot. Christiane Truelove, director of content...

Pharmalot… Pharmalittle… Good Morningmore

Hello, everyone, and nice to see you again. We are back from an extended weekend – a modest, but long overdue break –...

Pharmalot… Pharmalittle… Good Morningmore

Hello, everyone, and how was your weekend? We hope you are feeling refreshed and invigorated this morning, even if it...

China now carries a big compulsory-licensing stickmore

Drugmakers can count compulsory licensing among the new pitfalls of China's huge-and-growing drug market.

South Koreans eating up generic Viagramore

Two weeks after its patent expired in South Korea on the API in Viagra, Pfizer ($PFE) is seeing an explosion of generic...

Pharmalot… Pharmalittle… Good Morningmore

Top of the morning to you. The sun is shining brightly over the Pharmalot corporate campus and another lovely day...

Massachusetts May Overturn Its Coupon Banmore

If the Massachusetts budget becomes law next month, the state will finally join the rest of the nation and allow...

EU antitrust officials probe parallel trademore

Parallel trade in Europe has attracted the gimlet eye of antitrust regulators. EU investigators launched a probe into...

Pennsylvania still trying get a slice of J&J Risperdal payoutsmore

An appeal being heard today on a case seen as the precursor to the mountains of litigation over Johnson & Johnson's...

Top 10 Best-selling Cancer Drugs in 2011more

Oncology drugs are hot. Scratch beneath the surface of most major drugmakers, and you'll find a host of them in various...

UK Pharma Trade Group May Restrict Samplesmore

In a bid to tighten its voluntary code of practice, the Association of the British Pharmaceutical Industry has proposed...

Senate probes ties among narcoticsmakers, pain organizationsmore

The pharma industry's promotional practices are under scrutiny once again. This time, the spotlighted products are...

Pharmalot… Pharmalittle… Good Morningmore

Good morning, folks. How are you today? Some gloomy clouds are hovering over the Pharmalot corporate campus, but these...

Pharmalot… Pharmalittle… Good Morningmore

Good morning, everyone, and nice to see you again. We hope the weekend was refreshing. As for us, we are back from a...

Pfizer's DTC ad spending dwarfs rivalsmore

Last week, Advertising Age celebrated a big direct-to-consumer ad campaign that's in the works for Purdue Pharma's new...

Pfizer eyes ad agency work for cost-cuttingmore

After a series of ad agency shuffles over the past several years, Pfizer ($PFE) is conducting an overall review of its...

U.S. drug spending up, thanks to new drug launchesmore

The good news: New drugs do push up drug spending. At least that was the case in 2011, when U.S. spending on...

Oh, A Wise Guy, Eh? Then Stoogesta Is For Youmore

“Ever dropped a bell on a nun, ripped the armpit hair off an old man or stuffed a live lobster down a loved one’s...

France's drug spending will shrink for first time, IMS saysmore

Call it the French retrench. After two years of no growth, the drug market in France is projected to shrink 1% to 2%,...

Dr. Reddy's nears launch of Fujifilm venture, CFO saysmore

After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint...

Valeant nabs Russia's Natur Produkt for $175M-plusmore

We sound like a broken record when it comes to Valeant Pharmaceuticals ($VRX): The Canadian drugmaker has made yet...

Takeda scouts for M&A in India, plots Chinese growthmore

India and China are on most expansion-minded drugmakers' shopping lists. So, it's not a huge surprise that top Japanese...

Top Sources: Drug Marketing

  • News
  • medicinesocialjustice.blogspot.com
  • blogs.nature.com
  • carlatpsychiatry.blogspot.com
  • doseofdigital.com
  • drugreptoys.blogspot.com
  • cfpie.com
  • Pharmalot
  • CNBC
  • eyeonfda.com

Most Active Users in this Topic

see all contributors in Drug Marketing

Featured White Papers

Post a Job

Jobs in this Topic

SR EXECUTIVE ASSISTANT, DIABETES MARKETING Job Novo Nordisk | Princeton, NJ
Posted: Apr 23
Associate Director Global Marketing LEMTRADA Genzyme | Cambridge, MA
Posted: Mar 29
AD, DRUG REGULATORY AFFAIRS CMC Boehringer Ingelheim | California
Posted: May 1
Medical Operations Leader (drug safety pharmacovigilance) PAREXEL International | Durham, NC
Posted: Apr 25

Report comment contains invalid characters. ()
cancel
Search Cancel